Apyx Medical Shares Jump 7.9% After FDA Clears AYON for Power Liposuction
Updated
Updated · MarketWatch · May 11
Apyx Medical Shares Jump 7.9% After FDA Clears AYON for Power Liposuction
3 articles · Updated · MarketWatch · May 11
$3.96 shares of Apyx Medical rose 7.9% in Monday morning trading after the FDA expanded clearance for its AYON Body Contouring System.
The new clearance lets AYON perform power liposuction, a motor-assisted technique that uses a rapidly moving tube to remove fat faster and more efficiently.
Apyx said it will begin a limited commercial launch of the feature, using early adopters to refine training, utilization and customer experience before a broader rollout.
Nearly 40% gains over the past five days show investors are betting the added indication could widen AYON's appeal in the aesthetic-device market.
Will Apyx Medical's new all-in-one device dominate the booming post-GLP-1 body contouring market?
As body contouring technology advances, does a surgeon's artistic skill become more or less critical for patient results?